Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0019158 (hepatitis)
 30,205 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Endogenous and postheparin monoglyceride hydrolase (MGH) was studied in 9 patients with acute virus hepatitis and in 25 normal subjects with the use of a new spectrophotometric method. During the 4 weeks of observation the patients had significantly higher endogenous and reduced postheparin MGH levels if compared with the controls (p smaller than 0.001). In the initial phase of hepatitis the alterations were more pronounced and the serum glyceride concentration was raised. The results show that MGM activities in plasma may be greatly influenced by the liver.
 ...
PMID:Endogenous and postheparin monoglyceride hydrolase in plasma of patients with acute virus hepatitis. 114 11

The activity of monoglyceride lipase was studied in plasma from 74 patients with liver disease in whom blood was drawn 10 min after the injection of heparin (10 U/kg body weight). The results were compared with the activities from 29 healthy volunteers. For measurement a new, easy to handle method was used. The patients showed significantly lower activities, e.g. in chronic aggressive hepatitis there was a decrease by 87%. There was no correlation between the activities of monoglyceride lipase and pseudocholinesterase which also can be decreased in liver disease. The results show that the determination of monoglyceride lipase appears to be a useful test of the liver's function. Its value probably lies in the evaluation of the vessels.
 ...
PMID:[Clinical experience with a new method for the determination of monoglyceride lipase (author's transl)]. 125 30

The activity of pancreatic (alpha-amylase, protease, and lipase) and enteral (maltase, glycyl-L-leucine dipeptidase, monoglyceride lipase) was studied in the experiments on adult male Wistar rats weighting 350 +/- 35 g 1-3, 7, 10, 30, 60, and 90 days after injection of a single dose of 25 mg per 100 g body weight. Acute heliotrine intoxication (in a toxic hepatitis model) was shown to lead to a marked decrease in the activities of both pancreatic and intestinal enzymes. It is suggested that the changes may be associated with the direct action of heliotrine on the pancreas and small intestinal mucosa or with hepatic failure.
 ...
PMID:[Enzymatic activity of the pancreas and small intestinal mucosa in modelling of toxic hepatitis by administration of heliotrine]. 870 May 93

For many centuries, cannabis (marijuana) has been used for both recreational and medicinal purposes. Currently, there are about 192 million cannabis users worldwide, constituting approximately 3.9% of the global population. Cannabis comprises more than 70 aromatic hydrocarbon compounds known as cannabinoids. Endogenous circulating cannabinoids, or endocannabinoids, such as anandamide and 2-arachidonoyl-glycerol, their metabolizing enzymes (fatty acid amide hydrolase and monoacylglycerol lipase) and 2 G-protein coupled cannabinoid receptors, CB1 and CB2, together represent the endocannabinoid system and are present throughout the human body. In the gastrointestinal (GI) tract, the activated endocannabinoid system reduces gut motility, intestinal secretion and epithelial permeability, and induces inflammatory leukocyte recruitment and immune modulation through the cannabinoid receptors present in the enteric nervous and immune systems. Because of the effects of cannabinoids on the GI tract, attempts have been made to investigate their medicinal properties, particularly for GI disorders such as pancreatitis, hepatitis, and inflammatory bowel diseases (IBD). The effects of cannabis on IBD have been elucidated in several small observational and placebo-controlled studies, but with varied results. The small sample size and short follow-up duration in these studies make it difficult to show the clear benefits of cannabis in IBD. However, cannabis is now being considered as a potential drug for inflammatory GI conditions, particularly IBD, because of its spreading legalization in the United States and other countries and the growing trend in its use. More high-quality controlled studies are warranted to elucidate the mechanism and benefits of cannabis use as a possible option in IBD management.
 ...
PMID:Role of cannabis in inflammatory bowel diseases. 3212 34